专利号:EP-0671928-B1 优先权日:1992-09-24 标题 :Synthesis of n-substituted oligomers 发明人:ZUCKERMANN RONALD N; KERR JANICE M; KENT STEPHEN BRIAN HENRY; MOOS WALTER H; SIMON REYNA J; GOFF DANE A 权利人:CHIRON CORP 摘要:Poly N-substituted Glycines (poly NSGs), wherein the substituents bear purine or pyrimidine bases (R<9>) every second glycine: In addition, a solid phase method for the synthesis of N-substituted oligomers of more general structures is disclosed.The poly NSGs obtainable by this method can have a wide variety of side-chain substituents. Each N-substituted glycine monomer is assembled from two 'sub-monomers' directly on the solid support. Each cycle of monomer addition consists of two steps: (1) acylation of a secondary amine bound to the support with an acylating agent comprising a leaving group capable of nucleophilic displacement by -NH2, such as a haloacetic acid, and (2) introduction of the side-chain by nucleophilic displacement of the leaving group, such as halogen (as a resin-bound alpha -haloacetamide) with a sufficient amount of a second sub-monomer comprising an -NH2 group, such as a primary amine, alkoxyamine, semicarbazide, acyl hydrazide, carbazate or the like. Repetition of the two step cycle of acylation and displacement gives the desired oligomers. The efficient synthesis of a wide variety of oligomeric NSGs using the automated synthesis technology of the present method makes these oligomers attractive candidates for the generation and rapid screening of diverse peptidomimetic libraries. The oligomers of the invention, such as N-substituted glycines (i.e. poly NSGs) disclosed here provide a new class of peptide-like compounds not found in nature, but which are synthetically accessible and have been shown to possess significant biological activity and proteolytic stability.
专利号:US-9388131-B2 优先权日:2011-04-27 标题:Automated synthesis of small molecules using chiral, non-racemic boronates 发明人:BURKE MARTIN D; LI JUNQI; GILLIS ERIC P 权利人:UNIV ILLINOIS 摘要:Provided are methods for making and using chiral, non-racemic protected organoboronic acids, including pinene-derived iminodiacetic acid (PIDA) boronates, to direct and enable stereoselective synthesis of organic molecules. Also provided are methods for purifying PIDA boronates from solution. Also provided are methods for deprotection of boronic acids from their PIDA ligands. The purification and deprotection methods may be used in conjunction with methods for coupling or otherwise reacting boronic acids. Iterative cycles of deprotection, coupling, and purification can be performed to synthesize chiral, non-racemic compounds. The methods are suitable for use in an automated chemical synthesis process. Also provided is an automated small molecule synthesizer apparatus for performing automated stereoselective synthesis of chiral, non-racemic small molecules using iterative cycles of deprotection, coupling, and purification.
专利号:US-2019177392-A1 优先权日:2014-09-23 标 题 :Synthesis of glp-1 peptides 发明人:PENIAS NAVON SHARON; NAVEH SHIRLY; VASILEIOU ZOI; BARLOS KONSTANTINOS 权利人:NOVETIDE LTD 摘要:Disclosed are processes for the synthesis of GLP-1 peptides, such as liraglutide and semaglutide, and a process for purifying liraglutide.
专利号:US-6998484-B2 优先权日:2000-10-04 标 题:Synthesis of purine locked nucleic acid analogues 发明人:KOCH TROELS; JENSEN FLEMMING REISSIG 权利人:SANTARIS PHARMA AS 摘要:The present invention relates to a new method for the synthesis of purine LNA (Locked Nucleic Acid) analogues which provides a higher overall yield. The method comprising a regioselective 9-N purine glycosylation reaction followed by a one-pot nucleophilic aromatic substitution reaction of the 6-substituent in the purine ring and simultaneous nucleophile-induced intramolecular ring closure of the C-branched carbohydrate to form novel purine LNA analogues. The novel strategy is illustrated by the synthesis of the novel compound (1S,3R,4R,7S)-7-benzyloxy-1-methanesulfonylmethyl-3-(guanin-9-yl)-2,5-dioxabicyclo[2.2.1]heptane which is easily converted into (1S,3R,4R,7S)-7-hydroxy-1-hydroxymethyl-3-((2-N-isobutyrylguanin-9-yl)-2,5-dioxabicyclo[2.2.1]heptane after isobutyryl protection of the 2-amino purine group and subsequent substitution of 1-methanesulfonyl with benzoate, debenzoylation and debenzylation.
专利号:US-6040423-A 优先权日:1990-08-31 标题 :Process for synthesis of peptides 发明人:FRANK RONALD; GULER SINAN 权利人:BIOTECHNOLOG FORSCHUNG GMBH 摘要:The invention relates to a process for the rapid synthesis of support-bound or free peptides, a device for carrying out the process, a flat material with peptides bound to it which are prepared according to the process, and to a use for the flat material.
专利号:US-10364262-B2 优先权日:2012-07-17 标 题 :Method for the synthesis of N-phosphonomethyliminodiacetic acid 发明人:DEVAUX ALBERT; BURCK SEBASTIAN; NOTTE PATRICK 权利人:MONSANTO TECHNOLOGY LLC 摘要:A method for synthesis of N-phosphonoalkyliminodiacetic acid or derivatives thereof by forming a reaction mixture having an acid catalyst, a compound of the following general formula R1—CH2—NX—CH2—R2 and a compound having one or more P—O—P anhydride moieties to form a compound having a formula R1—CH2—N(—CH2PO3R32)(—CH2—R2) wherein in R1—CH2—NX—CH2—R2: X is —CH2—OH or —CH2—COOH; R1 and R2 are independently selected from the group consisting of nitrile, C1-C4 alkyl carboxylate, and carboxylic acid for when X is —CH2—OH, or R1 and R2 are both carbonyl groups linked by a hydrogen substituted nitrogen atom or a C1-C4-alkyl substituted nitrogen atom; and R3 is H, an alkyl group, or an aryl group; the anhydride moieties in the P—O—P anhydride compound have one P atom at the oxidation state (+III) and one P atom at the oxidation state (+III) or (+V); and 2) hydrolyzing the mixture to form N-phosphonomethyliminodiacetic acid or one of its derivatives.
[参考文献]: M D Loberg, Et Al. Development Of New Radiopharmaceuticals Based On N-Substitution Of Iminodiacetic Acid. J Nucl Med. 1976 Jul;17(7):633-8. [参考文献]: Misra Rk, Et Al. Iminodiacetic Acid Functionalized Cation Exchange Resin For Adsorptive Removal Of Cr(Vi), Cd(Ii), Ni(Ii) And Pb(Ii) From Their Aqueous Solutions. J Hazard Mater. 2011 Jan 30;185(2-3):1508-12. [参考文献]: Shihui Lin, Et Al. Explore Potential Plasma Biomarkers Of Acute Respiratory Distress Syndrome (Ards) Using Gc-Ms Metabolomics Analysis. Clin Biochem. 2019 Apr;66:49-56. [参考文献]: David Nette, Et Al. Determination Of Aminopolycarboxylic Acids At Ultra-Trace Levels By Means Of Online Coupling Ion Exchange Chromatography And Inductively Coupled Plasma-Mass Spectrometry With Indirect Detection Via Their Pd2-Complexes. Anal Chim Acta. 2015 Jul 16:884:124-32. [参考文献]: Dávid Suba, Et Al. Capillary Isoelectric Focusing Method Development And Validation For Investigation Of Recombinant Therapeutic Monoclonal Antibody. J Pharm Biomed Anal. 2015 Oct 10:114:53-61.
合成参考文献
参考文献:10.1007/s10126-011-9396-1 摘要:Samino S, Michibata H, Ueki T. Identification of a novel vanadium-binding protein by EST analysis on the most vanadium-rich ascidian, Ascidia gemmata. Mar Biotechnol (NY). 2012 Apr;14(2):143–54. doi: 10.1007/s10126-011-9396-1. 参考文献:10.1107/s1600536811013675 摘要:Qiang Y, Zhu S, Shao M. N,N′-Dicarboxy-N,N′-dicarboxylato(m-phenylene)dimethanaminium monohydrate. Acta Crystallogr E Struct Rep Online. 2011 Apr 22;67(5):o1174. doi: 10.1107/s1600536811013675. 参考文献:10.1007/s11033-011-1158-7 摘要:Sun J, Peng RH, Xiong AS, Tian Y, Zhao W, Xu H, Liu DT, Chen JM, Yao QH. Secretory expression and characterization of a soluble laccase from the Ganoderma lucidum strain 7071-9 in Pichia pastoris. Mol Biol Rep. 2012 Apr;39(4):3807–14. doi: 10.1007/s11033-011-1158-7. 参考文献:10.1016/j.bmcl.2011.06.064 摘要:Nemoto H, Ishihara A, Araki T, Katagiri A, Kamiya M, Matsushita T, Hattori H, Mimura Y, Tomoda Y, Yamasaki M. Improved performance by replacing iminodiacetic residues with glyceryl residues in symmetrically branched oligoglycerols. Bioorganic & Medicinal Chemistry Letters. 2011 Aug;21(16):4724–7. doi: 10.1016/j.bmcl.2011.06.064.